-+ 0.00%
-+ 0.00%
-+ 0.00%

Crinetics Pharmaceuticals Earnings Report: Q4 Overview

Benzinga·02/26/2026 21:22:20
Listen to the news

Crinetics Pharmaceuticals (NASDAQ:CRNX) just disclosed its Q4 earnings on Thursday, February 26, 2026 at 04:05 PM.

Here's a brief overview of the earnings report.

Earnings

Crinetics Pharmaceuticals beat estimated earnings by 5.84%, reporting an EPS of $-1.29 versus an estimate of $-1.37.

Revenue was up $6.16 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.12 which was followed by a 8.02% drop in the share price the next day.

Here's a look at Crinetics Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -1.26 -1.11 -0.95 -0.89
EPS Actual -1.38 -1.23 -1.04 -0.88
Revenue Estimate 1.32M 2.33M 100K 727K
Revenue Actual 143K 1.03M 361K 0

To track all earnings releases for Crinetics Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.